Measurement of changes in serum-based inflammatory indicators to monitor response to nivolumab monotherapy in advanced gastric cancer: a multicenter retrospective study.

MLA

Inukai, Michiko, et al. “Measurement of Changes in Serum-Based Inflammatory Indicators to Monitor Response to Nivolumab Monotherapy in Advanced Gastric Cancer: A Multicenter Retrospective Study.” BMC Cancer, vol. 24, no. 1, Sept. 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12885-024-12813-6.

APA

Inukai, M., Nishi, T., Matsuoka, H., Matsuo, K., Suzuki, K., Serizawa, A., Akimoto, S., Nakauchi, M., Tanaka, T., Kikuchi, K., Shibasaki, S., Uyama, I., & Suda, K. (2024). Measurement of changes in serum-based inflammatory indicators to monitor response to nivolumab monotherapy in advanced gastric cancer: a multicenter retrospective study. BMC Cancer, 24(1), 1–11. https://doi.org/10.1186/s12885-024-12813-6

Chicago

Inukai, Michiko, Tomohiko Nishi, Hiroshi Matsuoka, Kazuhiro Matsuo, Kazumitsu Suzuki, Akiko Serizawa, Shingo Akimoto, et al. 2024. “Measurement of Changes in Serum-Based Inflammatory Indicators to Monitor Response to Nivolumab Monotherapy in Advanced Gastric Cancer: A Multicenter Retrospective Study.” BMC Cancer 24 (1): 1–11. doi:10.1186/s12885-024-12813-6.